Clinical trials
Melanoma trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
273 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 10 |
| 2013 | 20 |
| 2014 | 5 |
| 2015 | 12 |
| 2016 | 19 |
| 2017 | 18 |
| 2018 | 19 |
| 2019 | 18 |
| 2020 | 15 |
| 2021 | 26 |
| 2022 | 25 |
| 2023 | 19 |
| 2024 | 16 |
| 2025 | 12 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 127 |
| Terminated | 50 |
| Active, not recruiting | 46 |
| Recruiting | 32 |
| Unknown status | 13 |
| Withdrawn | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 34 |
| Novartis Pharmaceuticals | 22 |
| Hoffmann-La Roche | 19 |
| Pfizer | 12 |
| Grupo Español Multidisciplinar de Melanoma | 11 |
| Merck Sharp & Dohme LLC | 9 |
| Amgen | 7 |
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| GlaxoSmithKline | 6 |
| AstraZeneca | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 273 |
| Carcinoma, Non-Small-Cell Lung | 67 |
| Neoplasms | 39 |
| Neoplasm Metastasis | 29 |
| Squamous Cell Carcinoma of Head and Neck | 29 |
| Carcinoma, Renal Cell | 28 |
| Colorectal Neoplasms | 26 |
| Triple Negative Breast Neoplasms | 23 |
| Skin Neoplasms | 21 |
| Ovarian Neoplasms | 18 |
Trials
Showing 76 to 100 of 273. Each trial links to its page on Pharma Observatory.
173 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.